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Abstract. 
 
The Rieger syndrome is an autosomal domi-
nant disease characterized by ocular, craniofacial, and
umbilical defects. Patients have mutations in PITX2, a
paired-bicoid homeobox gene, also involved in left/
right polarity determination. In this study we have iden-
tiﬁed a family of genes for enzymes responsible for hy-
droxylizing lysines in collagens as one group of likely
cognate targets of PITX2 transcriptional regulation.
The mouse procollagen lysyl hydroxylase (Plod)-2 gene
was enriched for by chromatin precipitation using a
 
PITX2/Pitx2-speciﬁc antibody. Plod-2, as well as the
human PLOD-1 promoters, contains multiple bicoid
(PITX2) binding elements. We show these elements to
bind PITX2 speciﬁcally in vitro. The PLOD-1 promoter
induces the expression of a luciferase reporter gene in
the presence of PITX2 in cotransfection experiments.
The Rieger syndrome causing PITX2 mutant T68P fails
to induce PLOD-1–luciferase. Mutations and rear-
rangements in PLOD-1 are known to be prevalent in
patients with Ehlers-Danlos syndrome, kyphoscoliosis
type (type VI [EDVI]). Several of the same organ sys-
tems are involved in Rieger syndrome and EDVI.
Key words: PITX2 • PLOD • Rieger • Ehlers-Danlos
• promoter
 
Introduction
 
Studies of the autosomal-dominant Rieger syndrome first
suggested that a single gene could be involved in the devel-
opment of eye, tooth, and abdominal organs (Rieger, 1935).
Mutations in PITX2 were detected in patients with Rieger
syndrome (Semina et al., 1996). The ocular abnormalities in-
clude an anterior and prominent Schwalbe’s line (posterior
embryotoxon), iris adhesions to the trabecular meshwork,
iris hypoplasia, ectopic pupils, displaced pupils, full-thickness
iris tears (polycoria), iridocorneal adhesions, and glaucoma.
Patients with Rieger (or Axenfeld-Rieger) syndrome display
the ocular features in combination with dental and umbilical
abnormalities. The dental phenotypes are hypoplasia, miss-
ing upper incisors, and sometimes total lack of teeth. The
umbilicus is usually a protruding stump, but severe cases
have omphalocele, or an unclosed abdomen. Mice disrupted
in the Pitx2 gene display phenotypes reminiscent of the cor-
responding human defects as well as symmetry defects
(Campione et al., 1999; Gage et al., 1999; Lin et al., 1999; Lu
et al., 1999). Pitx2 is also involved in the Nodal/Sonic hedge-
hog pathway, which determines left/right polarity of meso-
derm-derived organs such as heart, gut, and stomach (for re-
views see Blum et al., 1999; Tamura et al., 1999).
 
The PITX genes are members of the bicoid class of the
homeodomain proteins. These have a lysine residue at
position nine of the third helix and are especially note-
worthy for a role in both DNA and RNA binding (Dub-
 
nau and Struhl, 1996; Amendt et al., 1998). In 
 
Drosophila
 
,
seven different target genes have been identified epistati-
cally and biochemically for bicoid (Driever and Nüsslein-
Volhard, 1989; Jackle and Sauer, 1993). Target genes for
Pitx2 have only been described for the pituitary; the pro-
lactin gene is synergistically upregulated by Pit-1 and
Pitx2 (Simmons et al., 1990; Szeto et al., 1996; Ryan and
Rosenfeld, 1997; Amendt et al., 1998. Other pituitary-spe-
cific Pitx2 target genes have also been described (Trem-
blay et al., 2000). Recently, we presented the first study
on Pitx2 protein expression in the eye, as well as directly
demonstrating asymmetric protein expression in the early
development of mouse gut, heart, and lung (Hjalt and
Murray, 2000).
PITX2 was first identified by positional cloning of the
4q25 locus, but only 40% of patients diagnosed with classi-
cal Rieger syndrome have PITX2 mutations (Semina et
al., 1996). Other loci for Rieger syndrome include RIEG2
on 13q14 and FKHL7/FOXE7 on 6p25 (for reviews see
Craig and Mackey, 1999; Amendt et al., 2000). Still unde-
scribed genes/loci for Rieger syndrome may be down-
stream of PITX2. It is also still unknown which genes are
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the cognate targets for PITX2 in left/right asymmetry reg-
ulation in the development of the heart, gut, and lung.
Chromatin precipitation is a direct method for in vivo
detection of target genes. It has been used successfully to
identify: ultrabithorax target genes (Gould et al., 1990),
polycomb-repressed domains in the bithorax complex
(Orlando and Paro, 1993), Pax-2 in vivo binding sites
(Phelps and Dressler, 1996), and a Hox-C8 target gene
(Tomotsune et al., 1993).
Here we identify some members of the procollagen lysyl
hydroxylase (PLOD)
 
1
 
 family, genes for enzymes that hy-
droxylate lysines in collagens, as cognate targets for Pitx2/
PITX2, by chromatin precipitation. The hydroxylysine res-
idues have two important functions: as attachment sites for
carbohydrate units and to provide stability to intermo-
lecular cross-links. Cross-links involving hydroxylysine-
derived aldehydes are more stable than those involving
lysine-derived aldehydes (Prockop and Kivirikko, 1984;
Kivirikko and Myllylä, 1985; Kivirikko et al., 1992).
Point mutations and rearrangements in the human
PLOD1 are causative for the Ehlers-Danlos syndrome, ky-
phoscoliosis type, type VI (EDVI), characterized by ocular,
muscular, and skin defects (Hyland et al., 1992; Heikkinen
et al., 1997; Valtavaara et al., 1997). The proximal promoter
regions of both PLOD-1 and Plod-2 harbor multiple bicoid
elements. We show these elements to bind the PITX2 pro-
 
tein in vitro, as well as activate a reporter gene in transient
transfection assays. A Rieger syndrome causing PITX2 mu-
tant, T68P, cannot induce the PLOD-1 promoter.
 
Materials and Methods
 
Chromatin Precipitation
 
We have previously characterized the Pitx2-specific antibody P2R10
(Hjalt and Murray, 2000). It was used to immunoprecipitate chromatin
bound in vivo to Pitx2. About 30 mouse E14 heads were fixed in 50 ml 4%
paraformaldehyde in PBS on ice for 30 min. The heads were washed gen-
tly with 30 ml PBS twice, then once with 30 ml 50 mM glycine-HCl, pH
7.5, and once again with 30 ml PBS. The heads were slurried in 15 ml PBS
supplemented with 1 ml 10
 
3
 
 concentrated general protease inhibitor
cocktail (Sigma-Aldrich), 200 
 
m
 
l saturated PMSF in isopropanol, and 20
mg powdered Calpain Inhibitor I/ALLN (Calbiochem-Novabiochem).
The heads were homogenized and then sonicated on ice four times for 30 s
with a 1/8 inch microtip at 30% (sonic dismembrator model 300; Fisher
Scientific). The sonicate was centrifuged for 2 min at 3,000 rpm in a swing-
ing bucket rotor. The supernatant extract was precleared for 15 min at
22
 
8
 
C with a 50% slurry of protein A–Sepharose CL4B in PBS (Amersham
Pharmacia Biotech). The supernatant of the preclearing step was incu-
bated with a P2R10-protein A–Sepharose CL4B affinity gel (prepared ac-
cording to the recommendations of the manufacturer) for 2 h at 4
 
8
 
C, with
a fresh 1 ml of general protease inhibitors. The gel was batch washed three
times for 10 min at 22
 
8
 
C with 15 ml 50 mM Tris-HCl, pH 7.5/500 mM
NaCl, then 3 times for 10 min with 15 ml 50 mM Tris-HCl, pH 7.5/100 mM
NaCl. The gel was suspended in a fresh 1 ml of the last wash solution and
treated with 100 
 
m
 
l proteinase K (Roche) at 55
 
8
 
C for 1 h (without SDS),
then stopped at 70
 
8
 
C for 3 min. The sample was treated with phenol/chlo-
roform, chloroform, and precipitated overnight at 
 
2
 
20
 
8
 
C with sodium ac-
etate and ethanol. The immunoenriched DNA was digested over night
with EcoRI, cloned into a 
 
l
 
ZAPExpress vector (Stratagene), and pack-
aged into phage particles (GigaPack III Gold; Stratagene), producing a
primary library of 1.7
 
 3 
 
10
 
5
 
 independent clones. Clones were chosen at
 
1
 
Abbreviations used in this paper: 
 
BAC, bacterial artificial chromosome;
CMV, cytomegalovirus; EDVI, Ehlers-Danlos syndrome type VI; EMSA,
electrophoretic mobility shift assay; PLOD, procollagen lysyl hydroxylase;
RT, reverse transcription; TK, thymidine kinase.
 
Table I. Primers Used
 
Gene Forward (name) Reverse (name)
Annealing
temperature Size
 
bp
 
Primer pairs for BAC library screening
Plod-2 AGAGGCGGTGATGGAATGAACA (b18-s2) CTACAAAACACTCGGTAAACAAGAT (b18-15) 63
 
8
 
C 121
PLOD-1 CCTGGGGCTGCTCTAAGTGC (p1-21) CCCTGCCGTCTCCCTCCCTTCTCT (p1-8) 68
 
8
 
C 232
Primer pairs for RT-PCR
Pitx2 GCCAGCAAGGAAAGAATGAGGAT (Pitx2-1) CGTAGACACTTGGGGACATTCCTT (Pitx2-6) 67
 
8
 
C 950
PITX2 CCGAGGACCCGTCTAAGAAGAAGC (PITX2-5) GCATACTGGCAAGCACTCAGGT (PITX2-2) 67
 
8
 
C 709
Plod-1 GGGAGGACTGGAGTGTGGAT (m1-10) CAGGTTCTGGAAGATTCGGCAGCGAT (m1-11) 67
 
8
 
C 451
Plod-2 CAATTACACTGTGAAGGTTCTTGGTC (b18-7) GCATAGCCAATAAAGCCTCCAGAAT (b18-rt) 67
 
8
 
C 333
PLOD-1 CAGATGGCTACTATGCCCGTTC (h1x59) CAAAGTGCTCCATCTCCTCCAC (h1x63) 67
 
8
 
C 437
PLOD-2 GACCAGAAGAAAATCTAAGTCAAGC (h2x29) AGTTCCTTTCATTCATCTCTGAT (h2x25) 67
 
8
 
C 359
Oligodeoxyribonucleotides for EMSAs (only sense strand shown)
Bicoid ACGGCCCATCTAATCCCGTG
PLOD-1 C AAATATGAAATAATCCCACA
PLOD-1 H CTCACACCTGTAATCCCAGC
PLOD-1 J CACATGCCTGTAATCCCAGC
PLOD-2 C ATTTTTGTTTTCATCCCTAAACACAAA
PLOD-2 E TTTACACTTTTAGTCCCAGGATTTAAA
PLOD-2 F CATAGACATACTAATCAAAACCCAAAG
PLOD-2 G TGGCTGCTCTTAAGCCCAAAATCATGA
Primer pairs for quantitative PCR*
18S-rDNA AGCCTATTCTTTTTACTGGCTTGG (18S1F) GGAAGCGTGGCTCGGG (18S1R)
Prolactin CCTGCTGTTCTGCCAAAATGT (TMPL-1) CGGAGAGAAGTCTGGCAGTCA (TMPL-2)
Plod-2 CAGAAGGAACAGCTGGGAGTG (TMP1F) GTGGTGACTGCGAGGGCTT (TMP1RN)
TacMan probe ACAAGCGCCTACTCAGCCAAGCAGAC (TMm2-1)
 
*See Materials and Methods for product size and conditions. 
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random, excised using the ExAssist helper phage, prepared as plasmids,
and the inserts were cleaved out and labeled with [
 
32
 
P]dCTP. The labeled
inserts were used as probes for genomic Southern analyses and to probe a
portion of the unamplified library in a plaque hybridization assay. Some-
times vector backbone DNA was difficult to separate from insert on a gel
(same size). In these cases, vector T3 and T7 primers were used to PCR
amplify the insert for probe production.
 
Bacterial Artificial Chromosome Screening
and Sequencing
 
We screened bacterial artificial chromosome (BAC) libraries by PCR and
BAC clones in pBeloBac11 were obtained from Research Genetics
(mouse Plod-2, 249B6; human PLOD-1, 33A19). BAC DNA was pre-
pared and sequenced directly as described previously (Hjalt and Murray,
1999).
 
Electrophoretic Mobility Shift Assay
 
Oligodeoxyribonucleotides (see Table I and Fig. 2) were synthesized (In-
tegrated DNA Technologies) in complementary pairs, annealed to form
double stranded DNA, and labeled by kinasing with [
 
g
 
-
 
32
 
P]ATP. The
probes were purified on Sephacryl S-200 Microspin columns (Amersham
Pharmacia Biotech) and the activity was measured by scintillation count-
ing. Bacterially overexpressed PITX2 was prepared as described previ-
ously (Hjalt and Murray, 2000). Electrophoretic mobility shift assays
(EMSAs) were performed essentially as described in Amendt et al.
(1998). The Plod-2 G probe was modified from the sequence in the pro-
moter. The wild-type Plod-2 G probe would form concatemers during an-
nealing (not shown). The GC-rich 3
 
9
 
 sequence (GCGCCGCGGG) was
substituted for an arbitrary AT-rich sequence (AAAATCATGA).
 
Reverse Transcription PCR
 
Mouse mRNA was prepared from freshly dissected mouse tissues using a
Micro Fast Track kit (Invitrogen). Human cDNAs were purchased from
CLONTECH Laboratories, Inc. 20-
 
m
 
l reverse transcription (RT) reac-
tions were performed using a semianchored oligo-dT primer and Super-
script II reverse transcriptase (GIBCO BRL) according to the recommen-
dations of the manufacturer. The cDNAs were diluted four or six times in
10 mM Tris-HCl, pH 8.5, and 1 
 
m
 
l was used per PCR reaction. The prim-
ers used for PCR are listed in Table I. Standard 10- or 20-
 
m
 
l PCR reac-
tions were started hot. Cycling conditions: 35 cycles of 30 s at 94
 
8
 
C, X
 
8
 
C
for 1 min, 72
 
8
 
C for 1 min, and one cycle at 72
 
8
 
C for 1 min 30 s. Annealing
temperatures (“X”) are listed in Table I. The primer pairs chosen for
PITX2/Pitx2 amplify most known cDNA isoforms. All primer pairs were
designed with one to two intervening intron boundaries, and in some cases
also with one primer straddling another intron–exon boundary.
 
Real-Time PCR
 
An ABI Prism Sequence Detector 7700, with the program Sequence De-
tector v1.7, was used for real-time PCR experiments, performed according
to the recommendations of the manufacturer. Primers (Table I) were de-
signed using PrimerExpress 1.5. Primers for 45S/18S rDNA amplify the
segment between nucleotides 251 and 315 (5
 
9
 
 of transcription initiation) in
GenBank/EMBL/DDBJ accession no. V00850. Primers for prolactin am-
plifies the segment between nucleotides 112–180 (exon 2) in GenBank/
EMBL/DDBJ accession no. X02892. The 18S and prolactin products were
detected using CyberGreen Master Mix (PerkinElmer). Primers for the
Plod-2 promoter amplifies the segment between 
 
2
 
535 and 
 
2
 
466 in Fig. 2
B. The Plod-2 product was detected using a TaqMan probe (Table I) and
TaqMan Master Mix (Applied Biosystems/Roche). 80 ng was used per re-
action for both the control and the immunoenriched mouse DNA in four
independent experiments. All PCR profiles were 50
 
8
 
C for 2 min, 95
 
8
 
C for
10 min, and 40 cycles at 94
 
8
 
C for 15 s, 60
 
8
 
C for 1 min. The differences in
threshold cycle value, 
 
D
 
Ct, were obtained by comparing the Ct values for
normal total mouse genomic DNA and immunoenriched mouse DNA.
The results were normalized to the corresponding 
 
D
 
Ct values for the con-
trol primer set, 18S ribosomal DNA, such that fold enrichment was calcu-
lated as: 2
 
[
 
D
 
Ct(18S) 
 
1 D
 
Ct(assayed
 
 
 
gene)]
 
.
 
Reporter and Expression Constructs
 
Parts of the PLOD-1 promoter sequence were cloned into the luciferase
gene expression vector pGL3 (Promega). Construct A, a 3,140-bp Apa1
fragment containing 10 bicoid elements and ending 37 bp upstream of
 
exon 1 (positions 265–3404, in GenBank/EMBL/DDBJ accession no.
AF081786; see Fig. 2 A), was excised from the human BAC 33A19 (Re-
search Genetics) and cloned into the Apa1 site of pBluescriptIISK
 
2
 
. The
reporter constructs were PCR amplified from this clone. The Plod-1 2561
luciferase reporter contains Plod-1 sequences from 
 
2
 
60 to 
 
2
 
880 and has
the TAATAA and CAAT boxes (see Fig. 2). The 5
 
9
 
 sense primer contains
a unique BamH1 site (underlined) linked to the Plod-1 sequence, 5
 
9
 
-
CGGGATCCCAAGAGTGAAACTCTGTCTC-3
 
9
 
, and the 3
 
9
 
 antisense
primer contains a unique HindIII site (underlined) 5
 
9
 
-CCCCAAGCTTC-
CCCGCCCCTCCACGCCC-3
 
9
 
. To make the Plod-1 261 luciferase re-
porter, the sequence from 
 
2
 
60 to 
 
2
 
3180 was PCR-amplified. The 5
 
9
 
 sense
primer contains BamH1 site (underlined) linked to the Plod-1 sequence,
5
 
9
 
-CGGGATCCAAGCAGTCCTCCTGCCTT-3
 
9
 
, and the above 3
 
9
 
 anti-
sense primer. The PCR products were digested with BamH1 and HindIII
isolated and ligated into thymidine kinase (TK)-luc (Amendt et al., 1999),
which was digested with BamH1 and HindIII to remove the TK promoter.
The Plod-1 sequences were cloned upstream of the luciferase gene. The
PCR profile consisted of 94
 
8
 
C for 1.5 min, 60
 
8
 
C for 2 min, and 72
 
8
 
C for 3
min for 30 cycles with Pfu DNA polymerase (Stratagene). A cytomegalo-
virus (CMV)–
 
b
 
-galactosidase reporter plasmid (CLONTECH Laborato-
ries, Inc.) was cotransfected in all experiments as a control for transfection
efficiency. Expression plasmids containing the CMV promoter linked to
the PITX2 DNA were constructed in pcDNA 3.1 MycHisC (Invitrogen)
as described previously (Amendt et al., 1998).
 
Cell Culture, Transient Transfections, Luciferase, and 
 
b
 
-Galactosidase Assays
 
CHO cells were cultured in DME supplemented with 5% FBS and peni-
cillin/streptomycin in 60-mm dishes and transfected by electroporation.
CHO cells were mixed with 2.5 
 
m
 
g of expression plasmids, 5 
 
m
 
g of reporter
plasmid, and 0.5 
 
m
 
g of CMV–
 
b
 
-galactosidase plasmid plated in 60-mm cul-
ture dishes and then fed with 5% FBS and DME. Electroporation of CHO
cells was at 360 V and 950 
 
m
 
F; cells were fed 24 h before transfection.
HeLa cells were mixed with 2.5 
 
m
 
g of expression plasmids, 5 
 
m
 
g of re-
porter plasmid, and 0.5 
 
m
 
g of CMV–
 
b
 
-galactosidase plasmid. HeLa cells
were electroporated at 220 V and 960 
 
m
 
F (Bio-Rad Laboratories), plated
in 60-mm culture dishes, and fed with 5% FBS and DME as described pre-
viously (Amendt et al., 1998). Cells were then lysed and assayed for re-
porter activities and protein content by Bradford assay (Bio-Rad Labo-
ratories). Luciferase was measured using reagents from Promega.
 
b
 
-Galactosidase was measured using the Galacto-Light Plus reagents
(Tropix, Inc.). All luciferase activities were normalized to 
 
b
 
-galactosidase
activity. Expression of transiently expressed PITX2 proteins has been
demonstrated previously (Amendt et al., 1998).
Figure 1. Clone B18 is immunoenriched by a Pitx2-specific anti-
body and hybridizes to single bands in a genomic Southern analy-
sis. (A) The insert of clone B18 from the chromatin precipitation
library was labeled and used to probe a filter with 30,000 plaques
of nonamplified immunoenriched library. At least five strong sig-
nals are apparent and indicate an enrichment factor of 165. (B)
Southern blot of total mouse DNA digested with PstI (lane 1)
and EcoRI (lane 2). 
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Results
 
Plod-2 Is Immunoenriched by P2R10
 
The nucleoprotein complexes of E14 mouse heads were im-
munoenriched by using a Pitx2-specific antibody (Hjalt and
Murray, 2000). The DNA was cloned into a phage library
by plaque PCR using T7 and T3 flanking vector primers
from 80 isolates; 90% contained inserts ranging in size from
100 to 8,000 bp, with an average size of 3,000 bp (not
shown). 20 clones were excised at random one by one and
inserts were labeled and used as probes for genomic South-
ern analyses and a plaque enrichment assay. One of the en-
riched clones, B18, that also represented a unique gene by
Southern analysis (Fig. 1), displayed DNA sequence homol-
ogy to mouse procollagen Plod-2. Normally, a 3,000-bp
fragment of the mouse genome should appear 0.03 times on
a 30,000 plaque filter (3E4 
 
3 
 
3E3/3E9). Five hits on the fil-
ter represent 165-fold enrichment. Control hybridization to
a normal mouse genomic library filter of equal density was
blank (not shown). The 2,701-bp B18 clone insert matched
Plod-2 and PLOD-2 cDNA sequences in BLAST searches.
Later we could confirm that B18 matched exon 7, intron 7,
and exon 8 of PLOD-2. Since enrichment of the Plod-2 gene
occurred before digestion with EcoRI and library cloning,
 
Table II. Enrichment Test by Real-Time PCR
 
Ct control Ct enriched
 
D
 
Ct
Enrichment
(fold)
 
18S 16.33 
 
6 
 
0.04 18.22 
 
6 
 
0.07 Down 1.89 NA*
Plod-2 32.88 
 
6 
 
0.30 29.76 
 
6 
 
0.09 Up 3.12 32
Prolactin 21.45 
 
6 
 
0.03 19.73 
 
6 
 
0.04 Up 1.72 12
 
n
 
 
 
5 
 
4.
*Not applicable.
Figure 3. PLOD-1 and Plod-2 promoter elements bind PITX2 in
vitro. (A) EMSA of PITX2 protein incubated with radioactively
labeled double stranded oligodeoxyribonucleotide probes de-
signed from the PLOD-1 promoter. Bic, Drosophila bicoid ele-
ment. For sequences of Bic and of elements C, H, and J see Fig. 2
and Table I. (B) EMSA of PITX2 protein incubated with probes
designed from the Plod-2 promoter. For sequences of elements
C, E, F, and G see Fig. 2 and Table I.
Figure 2. The proximal promoter sequences of PLOD-1 and
Plod-2. The proximal promoter DNA sequences of the human
PLOD-1 (A) and mouse Plod-2 (B) are shown. PITX2 binding el-
ements are in bold. The corresponding binding site names (A–J
and A–H) are listed on the right side. The transcriptional start
site of Plod-2 is not mapped, for reference purposes the 59-most
nucleotide of the cDNA (available from GenBank/EMBL/DDBJ
under accession no. NM_011961) is used as 11. Bicoid-like and
bicoid elements are in bold and boxed. In A, ApaI restriction
sites are underlined. CAAT and TAATAA sequences are un-
derlined with thick lines. These sequence data are available
from GenBank/EMBL/DDBJ under accession nos. AF081786
(PLOD-1) and AF283255 (Plod-2). 
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we knew it would be possible to clone parts of the gene
other than the promoter. We also confirmed that prolactin,
a known Pitx2 binder (Amendt et al., 1998), was immu-
noenriched by probing a set of filters with a probe for
mouse prolactin, exon 2 (not shown). Control hybridization
to a normal mouse genomic library filter of equal density
was blank (not shown). We also performed real-time PCR
on normal total mouse DNA and immunoenriched DNA of
the same concentrations. We used a primer set for 18S ribo-
somal DNA as a control and compared the results to those
for the Plod-2 promoter, or exon 2 for prolactin. The nor-
malized 
 
D
 
Ct values are presented in Table II. The Plod-2
promoter was enriched 32-fold and the prolactin exon 2 was
enriched 12-fold in this assay.
 
The Plod-2 Promoter Contains Multiple
Bicoid Elements
 
We screened a mouse genomic library and retrieved a
BAC clone containing the Plod-2 gene. We sequenced
2,551 bp upstream of where the 5
 
9
 
 end of the published
cDNA sequence starts. Here we discovered several sites
shown previously to bind 
 
Drosophila
 
 bicoid specifically by
DNaseI footprinting (Fig. 2). Sites A and C resemble the
“X3” site, and site D resembles the “X1/X2” sites (Ma et
al., 1996). Site F resembles the “B1” site (Driever and
Nüsslein-Volhard, 1989). Other similar sites have been
shown to bind bicoid specifically (Rivera-Pomar et al.,
1995; Dave et al., 2000). We confirmed that the C, E, F,
and G sites also bound PITX2 by EMSA (Fig. 3 B). Nega-
tive controls were performed for all probes (probe only),
but in Fig. 3 B only the control for the C probe is shown.
 
The PLOD-1 Promoter Contains Multiple
Bicoid Elements
 
We also studied the human PLOD-1 promoter, since the
sequence was available (GenBank/EMBL/DDBJ acces-
sion no. AF081786). Approximately 3 kb upstream of the
PLOD-1 5
 
9
 
 untranslated region we detected 10 bicoid ele-
ments (TAATCCC). We confirmed the in vitro binding
properties of some of these elements (C, E, and G) by
EMSA, using human PITX2 protein (Fig. 3 A) and syn-
thetic double stranded DNA.
 
PITX2 Regulates PLOD-1–luciferase Fusions in
Cell Culture
 
We proceeded to clone the PLOD-1 promoter in a lu-
ciferase reporter gene vector. We characterized the re-
sponse to PITX2 by cotransfecting the PLOD-1–luciferase
construct with a PITX2 expression vector. In CHO cells,
the PLOD-1 261 construct containing 10 bicoid elements
was activated 20-fold by PITX2A (Fig. 4 A). The minimal
promoter constructs, PLOD-1 2561, were modestly acti-
vated (approximately
 
 
 
fivefold) by PITX2. We attribute the
modest activation to the fact that two bicoid-like sites re-
main, one TAACCC and one TAAGCC, in the minimal
construct. Such elements are known to bind PITX2 in vitro
(Amendt, B., unpublished data). In HeLa cells, PLOD-1
was activated 6.5-fold by PITX2A (Fig. 4 B). Furthermore,
we found that a PITX2 gene carrying the Rieger syndrome
causing mutation T68P failed to upregulate PLOD-1 in
cell culture (Fig. 5). This protein can be expressed in cell
culture (Amendt et al., 1998). The responses were similar
to the negative controls both in CHO cells (Fig. 5 B) and
in HeLa cells (Fig. 5 C).
 
Coexpression in Several Mouse Tissues of Pitx2 with 
Plod-1 and Plod-2
 
We wanted to study which tissues Pitx2 was coexpressed in
with Plod-1 and Plod-2. We assayed this by RT-PCR of
mRNA isolated from various mouse tissue (Fig. 6).
The PCR primers for Pitx2 were designed to detect most
known isoforms (see Materials and Methods). First, we
Figure 4. PITX2 upregulates PLOD-1–luciferase
fusion constructs. The PLOD-1 promoter was fused
to a luciferase reporter gene and assayed for activa-
tion by PITX2A. (A) CHO cells. (B) HeLa cells. 
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could confirm that Pitx2, Plod-1, and Plod-2 are coex-
pressed in the tissue used to create the chromatin precipi-
tation library, mouse E14.5 heads (Fig. 6 A). Moreover,
we could confirm the same coexpression in E13.5 eyes
(Fig. 6 A). We also detected coexpression of PITX2,
PLOD-1, and PLOD-2 in adult human skeletal muscle
(Fig. 6 A). We also detected coexpression of Pitx2, Plod-1,
and Plod-2 in adult mouse heart and brain; of Pitx2 and
Plod-1 in adult mouse lung, skeletal muscle, and testis; and
Pitx2 and Plod-2 in mouse adult kidney (Fig. 6 B). In
mRNA from whole mouse embryos, we detected coex-
pression of Pitx2, Plod-1, and Plod-2 at E11 and E15 (Fig.
6 B). At E17, Pitx2 and Plod-2 were coexpressed. At E7,
Plod-1 and Plod-2 were expressed without Pitx2. This was
also the case in adult spleen. No expression was seen of ei-
ther gene in adult liver.
 
Clinical Similarities between Rieger and EDVI
 
We compared the reported clinical manifestations of
Rieger syndrome and EDVI. We used the database On-
line Mendelian Inheritance in Man (available at http://
www.ncbi.nlm.nih.gov/omim/) textbooks (e.g., Traboulsi,
1998), as well as published and unpublished clinical obser-
vations (May and Beauchamp, 1987; Wenstrup et al., 1989;
Heikkinen et al., 1997; Murray, J.C., unpublished). Several
similarities of organ system involvement are listed in Ta-
ble III. Most notable are the comparable ocular and ab-
dominal abnormalities.
 
Discussion
 
Several direct and indirect lines of evidence now support
the theory that the Plod genes belong to the cognate tar-
gets for Pitx2. (a) We were able to enrich for the Plod-2
gene 
 
z
 
170-fold in a chromatin precipitation assay using a
Pitx2/PITX2-specific antibody. This antibody does not
cross-react with PITX1 or PITX3 (Hjalt and Murray,
2000). However, we do not exclude the possibility that
Pitx1/Pitx3/PITX1/PITX3 might also be involved in the
regulation of the Plod/PLOD genes. Indeed, it has been
shown that PITX1 and PITX2 share DNA binding and
transactivating properties of target genes in the pituitary
(Tremblay et al., 2000). (b) The PLOD-1 and Plod-2 genes
contain clusters of bicoid elements in their proximal pro-
moter regions and we have shown that these elements
bind PITX2 in vitro. (c) We have shown that the proximal
PLOD-1 promoter can be induced to express a reporter
gene in the presence of PITX2. (d) The Rieger syndrome
causing PITX2 mutant T68P fails to induce the PLOD-1
reporter gene construct. (e) The EDVI patients share sev-
eral characteristics with the Rieger syndrome patients (Ta-
ble II). It is normally easy to distinguish these two disor-
ders from each other. However, the similarities of organ
systems involved pointed out here are indicative of the
role that lysine hydroxylation of collagens may play in
Rieger syndrome. (f) The EDVI patients also have defects
in tissues corresponding to where Pitx2 is expressed in the
mouse, such as cornea, skeletal muscle, aorta smooth mus-
Figure 5. Rieger syndrome mutant PITX2 T68P
fails to upregulate PLOD-1–luciferase fusion
constructs. The PLOD-1 promoter was fused to
a luciferase reporter gene and assayed for activa-
tion by PITX2A-T68P. (A) Location of the mu-
tation T68P in helix 2 of PITX2. A lysine residue
in helix 3, important for binding, is underlined.
(B) CHO cells. (C) HeLa cells.
 
Table III. Clinical Features of Rieger and
Ehlers-Danlos Syndromes
 
Clinical manifestations
Rieger
syndrome EDVI
 
Ocular
Glaucoma Yes* Yes*
Microcornea Yes
 
‡
 
Yes
 
‡
 
Cornea plana Yes
 
‡
 
Yes
 
‡
 
Blue sclera No Yes
 
‡
 
Fragile eyes/corneas No Yes
Iris hypoplasia Yes
 
‡
 
No
Iridocorneal adhesions Yes‡ No
Myopia No Yes‡
Dental
Tooth abnormalities Yes§ Yesi
Abdominal
Inguinal hernia Yes‡ Yes‡
Umbilical hernia Yes* Yes*
Omphalocele Yes* No
Skin hyperflexibility No Yes‡
Colon rupture No Yes*
*Less frequent.
‡Frequent.
§Microdontia, hypodontia, anodontia, and small crowns.
iDentinogenesis imperfecta.Hjalt et al. PITX2 Target Genes 551
cle, and skin (May and Beauchamp, 1987; Wenstrup et al.,
1989; Heikkinen et al., 1997; Hjalt and Murray, 2000). (g)
Plod-1 ESTs have been isolated from rabbit corneal en-
dothelial cells (Fujimaki et al., 1999) and strong Plod-like
enzymatic activity can be isolated from chick embryonic
corneas (Kao et al., 1983). These structures also strongly
express the Pitx2 protein in the mouse (Hjalt and Mur-
ray, 2000). We were also able to show coexpression of
Pitx2, Plod-1, and Plod-2 mRNA in mouse E13.5 eye by
RT-PCR.
It is also interesting to point out that Pitx2 is expressed
in mouse aorta smooth muscle and some EDVI patients
have aortic defects (Tsai and Grajewski, 1994; Cunning-
ham et al., 1998; Mammi et al., 1998). Rieger and ED syn-
dromes normally have different modes of inheritance, au-
tosomal dominant and recessive, respectively. However, it
is still unclear exactly what the link is between the pathol-
ogies of each syndrome.
Our finding that PITX2 regulates PLOD-1 differently in
different cellular backgrounds is indicative of the depen-
dence of cofactors for correct function of a homeobox
gene. The most appealing model for in vivo specificity of
homeobox genes is probably the binding site selection
model, in which cofactors define appropriate DNA bind-
ing site and later fine-tune expression levels (Mann and
Chan, 1996; Mann and Affolter, 1998). This model has re-
cently been very convincingly supported for Fushi tarazu,
which also can either activate or repress its cognate target
genes depending on cell type (Nasiadka et al., 2000). Fur-
thermore, the estimated amount of available Fushi tarazu
protein per cell is several orders of magnitude smaller than
the theoretically available cognate DNA binding sites
(Nasiadka et al., 2000). The support for the binding site se-
lection model also lends encouragement to methods such
as chromatin precipitation.
Some mouse tissues express Plod-1 and Plod-2 in the ab-
sence of Pitx2 (adult spleen and E7 whole embryo). It may
be that another Pitx family member regulates the Plod
genes in these tissues. Perhaps more likely is that Pitx2
serves as a modifier of gene expression, as is known to be
the case in the regulation of prolactin by PIT-1 and PITX2
(Simmons et al., 1990; Szeto et al., 1996; Ryan and Rosen-
feld, 1997; Amendt et al., 1998). Either protein, by itself,
accomplishes only modest transactivation of the prolactin
promoter, but together a dramatic synergistic effect on
gene expression is seen (Simmons et al., 1990; Szeto et al.,
1996; Ryan and Rosenfeld, 1997; Amendt et al., 1998). It
will be interesting and important to find the cognate cofac-
tors of Pitx2/PITX2 in the regulation of the Plod-1 and
2/PLOD-1 and 2 genes. Our discovery validates the chro-
matin precipitation method as a viable means of finding
additional target genes of PITX2.
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